OpenAlex
PricingAboutJobs
Log inGet started
Work

Methylated RASSF1a Is the First Specific DNA Marker for Minimal Residual Disease Testing in Neuroblastoma

HTML

Year: 2012
Type: article
Study design: Observational Study
Source: Clinical Cancer Research
DOI: 10.1158/1078-0432.ccr-11-0849
Authors: Janine Stutterheim, Fatima Ait Ichou, Emmy den Ouden, Rogier Versteeg, Huib N. Caron, Godelieve A.M. Tytgat, C. Ellen van der Schoot
Institutions: Amsterdam UMC Location University of Amsterdam, Sanquin, Emma Kinderziekenhuis
Language: English

Topic: Neuroblastoma Research and Treatments
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: neuroblastoma, minimal residual disease, RASSF1A, DNA methylation, PHOX2B, bone marrow, MRD quantification, overall survival, circulating tumor cells, prognostic factors
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2157684843
FWCI: 1.667
Cites: 29
Cited by: 36
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security